Corrigendum: Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy

• Yihui Zhou,
• Xiaomeng Gao,
• Meng Yuan,
• Bo Yang,
• Bo Yang,
• Qiaojun He,
• Qiaojun He,
• Qiaojun He,
• Ji Cao,
• Ji Cao,
• Ji Cao

Affiliations

Yihui Zhou

Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

Xiaomeng Gao

Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

Meng Yuan

The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, China

Bo Yang

Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

Bo Yang

The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, China

Qiaojun He

Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

Qiaojun He

The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, China

Qiaojun He

Cancer Center of Zhejiang University, Hangzhou, China

Ji Cao

Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

Ji Cao

The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, China

Ji Cao

Cancer Center of Zhejiang University, Hangzhou, China